Remove tag world-cancer-series
article thumbnail

Q&A: A decade on, what’s next for CAR-T therapies?

Pharmaceutical Technology

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. And coming back to the ISCT, we have a series of roundtables that go beyond the traditional didactic sessions, which address the issue of patient access. We must approach this on several fronts.

FDA 59
article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

Additional Information: Angela started a podcast series Diverse Perspectives where she interviews thought leaders from around the world who are bringing about change in a range of industries. Hatfield Economic Fellow at Cornell University in 2022. Birthplace: She spent her childhood in South Africa. LinkedIn Total experience: 27 yrs.

FDA 40
article thumbnail

A history of Johnson & Johnson

pharmaphorum

By most measures the single largest pharma company in the world, US-based Johnson & Johnson (J&J) is also arguably one of the most well-known drugmakers among the general public. . Following World War II, Ethicon’s market share in surgical sutures rose from 15% to 70% worldwide. joined the J&J Family of Companies.

Vaccines 116